These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 232340

  • 1. [Nonspecific prophylaxis and therapy of Pseudomonas aeruginosa wound-infections with paramunization using a mouse-model (author's transl)].
    Mayr A, Himmer B, Baljer G, Sailer J.
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):506-14. PubMed ID: 232340
    [Abstract] [Full Text] [Related]

  • 2. [Effectiveness of a new "paramunity" inducer (PIND-AVI) for human beings and animals].
    Stickl H, Mayr A.
    Fortschr Med; 1979 Oct 25; 97(40):1781-8. PubMed ID: 232054
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ, Gerçeker AA, Koles NL, Pollack M, Pier GB.
    Invest Ophthalmol Vis Sci; 1997 Jun 25; 38(7):1418-25. PubMed ID: 9191605
    [Abstract] [Full Text] [Related]

  • 6. [Radioprotective effectiveness of the paramunity inducer "pind-avi": investigation using the model "protective tetanic vaccination in mice" after exposure to X-rays (author's transl)].
    Mayr A, Baljer G, Sailer J, Schels D.
    Strahlentherapie; 1980 Nov 25; 156(11):795-9. PubMed ID: 6254210
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK, Cryz SJ, Hougen HP, Moser C, Høiby N.
    Behring Inst Mitt; 1997 Feb 25; (98):269-73. PubMed ID: 9382750
    [Abstract] [Full Text] [Related]

  • 9. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model.
    McVay CS, Velásquez M, Fralick JA.
    Antimicrob Agents Chemother; 2007 Jun 25; 51(6):1934-8. PubMed ID: 17387151
    [Abstract] [Full Text] [Related]

  • 10. [Experiences in the paraimmunization of cats in veterinary practice].
    Mayr-Bibrack B, Meyer H, Witteborg K.
    Tierarztl Prax; 1984 Jun 25; 12(3):359-68. PubMed ID: 6238448
    [Abstract] [Full Text] [Related]

  • 11. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment.
    Valdéz JC, Peral MC, Rachid M, Santana M, Perdigón G.
    Clin Microbiol Infect; 2005 Jun 25; 11(6):472-9. PubMed ID: 15882197
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung.
    Nieuwenhuis EE, Matsumoto T, Exley M, Schleipman RA, Glickman J, Bailey DT, Corazza N, Colgan SP, Onderdonk AB, Blumberg RS.
    Nat Med; 2002 Jun 25; 8(6):588-93. PubMed ID: 12042809
    [Abstract] [Full Text] [Related]

  • 15. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D, Serafińska D, Rudowski W, Hoffman S, Olański W, Gardzińska E, Popiel D, Jedrzejczak G, Czarnecka I.
    Pol Tyg Lek; 2002 Jun 25; 44(43-45):924-7. PubMed ID: 2518666
    [Abstract] [Full Text] [Related]

  • 16. Cytokine modulating effect of ginseng treatment in a mouse model of Pseudomonas aeruginosa lung infection.
    Song Z, Moser C, Wu H, Faber V, Kharazmi A, Høiby N.
    J Cyst Fibros; 2003 Sep 25; 2(3):112-9. PubMed ID: 15463859
    [Abstract] [Full Text] [Related]

  • 17. Intranasal immunisation with conjugate vaccine protects mice from systemic and respiratory tract infection with Pseudomonas aeruginosa.
    Zuercher AW, Horn MP, Wu H, Song Z, Bundgaard CJ, Johansen HK, Høiby N, Marcus P, Lang AB.
    Vaccine; 2006 May 15; 24(20):4333-42. PubMed ID: 16600444
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G.
    Expert Rev Vaccines; 2005 Oct 15; 4(5):645-56. PubMed ID: 16221066
    [Abstract] [Full Text] [Related]

  • 20. Experimental studies on bacterial product CANTASTIM derived from Pseudomonas aeruginosa. II. Protective effect in Salmonella typhimurium infection.
    Salageanu A, Ceacareanu B, Popescu D, Istrate N, Szegli G.
    Roum Arch Microbiol Immunol; 1997 Oct 15; 56(1-2):17-26. PubMed ID: 9558972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.